MRNA Operating Expenses
$3.04BTTM · USD
Period ending:
MRNA FY Operating ExpensesUSD
$6.39B$0.00
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
MRNA operating expenses history
Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | Operating Expenses (USD) |
|---|---|
| 4,150,000,000 | |
| 5,680,000,000 | |
| 6,394,000,000 | |
| 4,039,000,000 | |
| 1,823,000,000 | |
| 1,527,355,000 | |
| 574,908,000 | |
| 94,252,000 | |
| 454,644,000 | |
| 317,053,000 |
Compare operating expenses
All MRNA financial metrics · MRNA stock overview · How to interpret financial metrics
